Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.
de Lau LM, Stricker BH, Breteler MM. Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease. Mov Disord. 2007 Oct 15; 22(13):1985.
View in:
PubMed
subject areas
Aged
Anticholesteremic Agents
Cholesterol
Cholesterol, LDL
Coenzymes
Cohort Studies
Female
Follow-Up Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Male
Middle Aged
Parkinson Disease
Proportional Hazards Models
Prospective Studies
Risk Factors
Ubiquinone
authors with profiles
Monique M. Breteler, Ph.D., M.D.